Corcept Therapeutics IncorporatedEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 118.32 USD | 122,205 USD | 28,66 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 115 USD | 4 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 107.351.594 | 11,36 | 8,85 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Corcept Therapeutics Incorporated
Mitarbeiter 730
Handelsplatz NASDAQ
Ticker Symbol CORT
IPO Datum 2004-04-14
Adresse 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Webseite https://www.corcept.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director |
| 2 | Mr. Atabak Mokari | CFO & Treasurer |
| 3 | Mr. Sean Maduck | President of Endocrinology |
| 4 | Dr. William Guyer Pharm.D. | Chief Development Officer |
| 5 | Mr. Gary Charles Robb J.D. | Chief Business Officer & Secretary |
| 6 | Mr. Joseph Douglas Lyon | Chief Technology & Accounting Officer |
| 7 | Dr. Hazel Hunt Ph.D. | Chief Scientific Officer |
| 8 | Ms. Amy Flood | Chief Human Resources & Communications Officer |
| 9 | Ms. Monica Tellado | President of Emerging Markets |
| 10 | Mr. Roberto W. Vieira | President of Oncology |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | Ingalls & Snyder LLC | 0,00% | 0,00 Mio. USD |
| 4 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Parallel Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 10 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | First Trust Advisors L.P. | 0,00% | 0,00 Mio. USD |
| 12 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 13 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 14 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 15 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 16 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 17 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 18 | MPM Oncology Impact Management LP | 0,00% | 0,00 Mio. USD |
| 19 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 20 | HPM Partners LLC | 0,00% | 0,00 Mio. USD |